Related Experiment Video
Updated: Jun 9, 2025

Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera
Published on: May 23, 2025
Use of Cell-Free DNA Testing to Diagnose Infective Endocarditis in a Patient With Negative Blood Cultures
Robert Hennis1, Mark A Raynor1, Rivers A Hock1
1Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, USA.
Abstract:
Infective endocarditis (IE) is associated with significant morbidity and mortality. Its diagnosis can be especially challenging, as can the identification of a causative pathogen, which, in turn, is crucial for appropriate management. Here, we present a rare case of Streptococcus intermedius endocarditis complicated by lung and cerebral abscess in which clinicians employed cell-free deoxyribonucleic acid (cfDNA) testing to confirm the diagnosis, establish a causative pathogen, and determine appropriate antibiotic therapy. Notably, the positive cfDNA test prevented the need for brain biopsy in this case and has implications for diagnostic and therapeutic guidelines.
Insights
This study highlights a rare case of Streptococcus intermedius infective endocarditis. Cell-free DNA (cfDNA) testing successfully identified the pathogen and guided treatment, avoiding invasive procedures.
Area of Science:
- Infectious Diseases
- Cardiology
- Neurology
Background:
- Infective endocarditis (IE) presents diagnostic challenges, impacting patient morbidity and mortality.
- Identifying the causative pathogen is critical for effective IE management and treatment.
- Rare presentations of IE require innovative diagnostic approaches.
Observation:
- A rare case of Streptococcus intermedius infective endocarditis was observed.
- The patient developed complications including lung and cerebral abscesses.
- Standard diagnostic methods were challenging in this complex IE case.
Findings:
- Cell-free deoxyribonucleic acid (cfDNA) testing was utilized to diagnose IE.
- cfDNA testing successfully identified Streptococcus intermedius as the causative pathogen.
- This diagnostic approach guided appropriate antibiotic therapy and patient management.
Implications:
- Positive cfDNA test results obviated the need for invasive brain biopsy.
- This case demonstrates the potential of cfDNA testing in complex IE diagnosis.
- Findings suggest cfDNA testing may influence future diagnostic and therapeutic guidelines for IE.
More Related Videos
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis II: Clinical features and Diagnostic Tests
Myocarditis II: Clinical features and Diagnostic Tests

